Liladros

Drospirenone/Ethinylestradiol, the active ingredient in Liladros, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy and helps regulate menstrual cycles in women of reproductive age.

GNH USA supplies Liladros as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Liladros, a combined oral contraceptive, is used to manage hormonal pathways related to ovulation and menstrual regulation.

Prevention of pregnancy: provides reliable contraceptive protection by suppressing ovulation. Menstrual cycle regulation: helps achieve more predictable bleeding patterns and reduce menstrual discomfort.

Liladros may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Nausea: mild stomach upset, especially when starting therapy. - Breast tenderness: temporary swelling or discomfort. - Headache: mild to moderate intensity. - Spotting between periods: irregular light bleeding.

Serious or Rare Side Effects: - Blood clots: deep vein thrombosis or pulmonary embolism. - Severe hypertension: sudden increase in blood pressure. - Liver problems: jaundice or abnormal liver function tests.

Before prescribing Liladros, clinicians should evaluate individual risk factors and counsel patients on safe use. - Smoking: avoid smoking, especially if over 35 years old. - Cardiovascular risk: assess history of thromboembolic disorders. - Liver disease: use with caution in hepatic impairment. - Migraine: avoid if history of migraine with aura. - Medication adherence: take tablet at the same time daily. - Store at ambient temperature: keep below 25°C, retain in original pack, protect from moisture.

Liladros can interact with other medicines, requiring attention to avoid reduced effectiveness or increased adverse effects.

Major Interactions (Avoid): - Rifampin and other strong CYP3A4 inducers: may reduce contraceptive effectiveness. - Certain anticonvulsants (e.g., carbamazepine, phenytoin): may lower hormone levels. - St. John's wort: can decrease plasma concentrations of contraceptive hormones.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs): may increase risk of mood changes. - Antihypertensives (e.g., ACE inhibitors): may affect blood pressure control.